Sen. Grassley Seeks More Documents From Northwestern On Edwards’ Valve Inquiry
This article was originally published in The Gray Sheet
Executive Summary
The Iowa Republican says Northwestern Memorial Hospital may have held back materials in response to his 2008-launched inquiry into use of an Edwards Lifesciences heart valve repair device without FDA clearance or proper patient consent.
You may also be interested in...
FDA Listens To Industry Feedback On 510(k) Modifications Guidance Revisions
In a report to Congress, FDA stuck with device industry recommendations to merely revise its 1997 guidance on 510(k) device modifications, rather than to more thoroughly revamp the policy.
Grassley Wants More Active FDA Oversight Of 510(k) Modification Decisions
Sen. Chuck Grassley, R-Iowa, is questioning why FDA does not play a more active role in determining when a change to a device requires a new 510(k)
Edwards’ Mitral Valve Repair Device Withdrawn, Under Scrutiny
Edwards Lifesciences removed a mitral valve repair device from the market in October and submitted a 510(k) for the product in the midst of an FDA inquiry into whether the device was being marketed without proper clearance